Aspirin increases ferritin synthesis in endothelial cells -: A novel antioxidant pathway

被引:91
作者
Oberle, S [1 ]
Polte, T [1 ]
Abate, A [1 ]
Podhaisky, HP [1 ]
Schröder, H [1 ]
机构
[1] Univ Halle Wittenberg, Sch Pharm, Dept Pharmacol & Toxicol, D-06099 Halle, Germany
关键词
aspirin; ferritin; endothelial cell; gene expression; antioxidant defense mechanism;
D O I
10.1161/01.RES.82.9.1016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aspirin has recently been shown to increase endothelial resistance to oxidative damage, However, the mechanism underlying aspirin-induced cytoprotection is still unknown. Using cultured cells, the present study investigates the effect of aspirin on the expression of ferritin, a cytoprotective protein that sequesters free cytosolic iron, the main catalyst of oxygen radical formation. In bovine pulmonary artery endothelial cells, aspirin at low antithrombotic concentrations (0.03 to 0.3 mmol/L) induced the synthesis of ferritin protein in a time-and concentration-dependent fashion up to 5-fold over basal levels, whereas ferritin H (heavy chain) mRNA remained unaltered. Aspirin-induced cytoprotection from hydrogen peroxide toxicity was mimicked by exogenous iron-free apoferritin but not iron-loaded ferritin, demonstrating the antioxidant function of newly synthesized ferritin under these conditions. Ferritin induction by aspirin was specific in that other nonsteroidal anti-inflammatory drugs such as salicylic acid, indomethacin, or diclofenac failed to alter ferritin protein levels. Aspirin-induced ferritin synthesis was abrogated in the presence of the iron chelator desferrioxamine, pointing to an interaction of aspirin with iron-responsive activation of ferritin translation. Together, our results suggest induction of ferritin as a novel mechanism by which aspirin may prevent endothelial injury in cardiovascular disease, eg, during atherogenesis.
引用
收藏
页码:1016 / 1020
页数:5
相关论文
共 38 条
[1]   INVOLVEMENT OF TYROSINE KINASE IN THE INDUCTION OF CYCLOOXYGENASE AND NITRIC-OXIDE SYNTHASE BY ENDOTOXIN IN CULTURED-CELLS [J].
AKARASEREENONT, P ;
MITCHELL, JA ;
APPLETON, I ;
THIEMERMANN, C ;
VANE, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (04) :1522-1528
[2]   THE MODE OF ACTION OF ASPIRIN-LIKE DRUGS - EFFECT ON INDUCIBLE NITRIC-OXIDE SYNTHASE [J].
AMIN, AR ;
VYAS, P ;
ATTUR, M ;
LESZCZYNSKAPIZIAK, J ;
PATEL, IR ;
WEISSMANN, G ;
ABRAMSON, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7926-7930
[3]   THE IRON-BINDING AND HYDROXYL RADICAL SCAVENGING ACTION OF ANTI-INFLAMMATORY DRUGS [J].
ARUOMA, OI ;
HALLIWELL, B .
XENOBIOTICA, 1988, 18 (04) :459-470
[4]  
BALLA G, 1992, J BIOL CHEM, V267, P18148
[5]   TRANSFERRIN - A POTENTIAL SOURCE OF IRON FOR OXYGEN FREE RADICAL-MEDIATED ENDOTHELIAL-CELL INJURY [J].
BRIELAND, JK ;
CLARKE, SJ ;
KARMIOL, S ;
PHAN, SH ;
FANTONE, JC .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1992, 294 (01) :265-270
[6]   INDUCTION OF FERRITIN SYNTHESIS BY OXIDATIVE STRESS - TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION BY EXPANSION OF THE FREE IRON POOL [J].
CAIRO, G ;
TACCHINI, L ;
POGLIAGHI, G ;
ANZON, E ;
TOMASI, A ;
BERNELLIZAZZERA, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (02) :700-703
[7]   SUPPRESSION OF THROMBOXANE-A2 BUT NOT OF SYSTEMIC PROSTACYCLIN BY CONTROLLED-RELEASE ASPIRIN [J].
CLARKE, RJ ;
MAYO, G ;
PRICE, P ;
FITZGERALD, GA .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (16) :1137-1141
[8]  
CRCHTON RR, 1987, EUR J BIOCHEM, V164, P485
[9]   COMPARISON OF INVITRO-CELL CYTO-TOXIC ASSAYS FOR TUMOR NECROSIS FACTOR [J].
FLICK, DA ;
GIFFORD, GE .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 68 (1-2) :167-175
[10]   ASPIRIN AS A THERAPEUTIC AGENT IN CARDIOVASCULAR-DISEASE [J].
FUSTER, V ;
DYKEN, ML ;
VOKONAS, PS ;
HENNEKENS, C .
CIRCULATION, 1993, 87 (02) :659-675